ClinicalMetric / Countries / Netherlands / parkinson disease
← 🇳🇱 Netherlands Trials
🇳🇱 Netherlands Country × Condition

parkinson disease Clinical Trials in Netherlands

Active clinical trials for parkinson disease with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇳🇱 Netherlands

Active Trials in Netherlands (3)

NCT06582355
Recruiting

FMRI-neurofeedback in Parkinson's Disease

Enrollment
60 pts
Country
🇳🇱 Netherlands
Maastricht University Medical Cente...
View Trial →
NCT06142448
Recruiting

The Effect of Compensation Strategies on Gait Impairment in Parkinson's Disease

Enrollment
384 pts
Country
🇳🇱 Netherlands
Radboud University Medical Center
View Trial →
NCT04681534
Recruiting

Safety and Efficacy of Adaptive Deep Brain Stimulation

Enrollment
15 pts
Country
🇳🇱 Netherlands
Newronika
View Trial →

Frequently Asked Questions

How many parkinson disease clinical trials are active in Netherlands?
There are currently 3 active clinical trials for parkinson disease with sites in Netherlands, of which 3 are actively recruiting patients.
How can I join a parkinson disease clinical trial in Netherlands?
To join a parkinson disease clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are parkinson disease trials in Netherlands?
Active parkinson disease trials in Netherlands span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Netherlands Trials → Global parkinson disease Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology